Megan Sandy
Physician Assistant · Salt Lake City, UTNPI 1568713246
Payments from drug & device makers
Across 75 payments — averaging $18.37 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$703
- Pfizer$72
- GSK$60
- Lilly USA, LLC$60
- Novo Nordisk$52
- Bayer$41
- plus $389 from 18 others
What the payments were for
- Food & beverage$1,378100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 35 | $703 |
| Pfizer | 5 | $72 |
| GSK | 4 | $60 |
| Lilly USA, LLC | 4 | $60 |
| Novo Nordisk | 3 | $52 |
| Bayer | 2 | $41 |
| Merck | 2 | $38 |
| Biohaven Pharmaceuticals, Inc. | 2 | $37 |
| Collegium Pharmaceutical, Inc. | 2 | $29 |
| Lucid Diagnostics Inc. | 2 | $28 |
| Axsome Therapeutics, Inc. | 1 | $25 |
| Johnson & Johnson | 1 | $23 |
| Xeris Pharmaceuticals, Inc. | 1 | $22 |
| Abbott | 1 | $20 |
| Boehringer Ingelheim | 1 | $19 |
| Sanofi-aventis U.S. LLC | 1 | $19 |
| Astellas Pharma US Inc | 1 | $19 |
| Boston Scientific | 1 | $18 |
| Nevro Corp. | 1 | $18 |
| Esperion Therapeutics, Inc. | 1 | $18 |
| Sanofi Pasteur Inc. | 1 | $16 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $14 |
| AstraZeneca | 1 | $13 |
| Upsher-smith Laboratories LLC | 1 | $12 |
How this compares
$1,378 in reported general payments places this provider in the 75th percentile of 1,543 physician assistant providers in Utah.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Xtampza ErOxycodone Myristate | 30 | $16,185 |
| MounjaroTirzepatide | 12 | $13,234 |
| Fentanyl | 15 | $1,936 |
| Omeprazole | 54 | $1,384 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 62 | $1,280 |
| Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine | 26 | $1,118 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 39 | $1,057 |
| Morphine Sulfate ErMorphine Sulfate | 56 | $1,027 |
| Oxycodone Hcl | 70 | $1,001 |
| Potassium Chloride | 27 | $646 |
| Gabapentin | 34 | $600 |
| Duloxetine Hcl | 16 | $478 |
| Metformin Hcl | 29 | $462 |
| Bupropion XlBupropion Hcl | 24 | $442 |
| Atorvastatin Calcium | 40 | $411 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Collegium Pharmaceutical, Inc.Xtampza Er | $29 | $16,18530 claims |
| Lilly USA, LLCMounjaro | $60 | $13,23412 claims |
| Upsher-smith Laboratories LLCTopiramate | $12 | $21931 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 1,543 physician assistant providers in Utah.
Other physician assistant in Salt Lake City
- Jill EricksonSalt Lake City$179K
- Natalie BeeSalt Lake City$63K
- Samuel ShewanSalt Lake City$22K
- Christy MaSalt Lake City$17K
- Shane FarrSalt Lake City$14K
- Gintare DaileySalt Lake City$13K
- Corey DahlSalt Lake City$13K
- David JonesSalt Lake City$12K
- Corbin WoodSalt Lake City$12K
- Amy HillierSalt Lake City$11K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.